CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells
- PMID: 22948298
- PMCID: PMC3519411
- DOI: 10.1038/jcbfm.2012.123
CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells
Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common hereditary vascular dementia caused by mutations in NOTCH3 gene. Pathology is manifested in small- and middle-sized arteries throughout the body, though primarily in cerebral white matter. Hemodynamics is altered in CADASIL and NOTCH3 is suggested to regulate actin filament polymerization and thereby vascular tone. We analyzed NOTCH3 expression and morphology of actin cytoskeleton in genetically genuine cultured human CADASIL vascular smooth muscle cells (VSMCs) (including a cell line homozygous for p.Arg133Cys mutation) derived from different organs, and in control VSMCs with short hairpin RNA (shRNA)-silenced NOTCH3. NOTCH3 protein level was higher in VSMCs derived from adult than newborn arteries in both CADASIL and control VSMCs. CADASIL VSMCs showed altered actin cytoskeleton including increased branching and node formation, and more numerous and smaller adhesion sites than control VSMCs. Alterations in actin cytoskeleton in shRNA-silenced VSMCs were similar as in CADASIL VSMCs. Severity of the alterations in actin filaments corresponded to NOTCH3 expression level being most severe in VSMCs derived from adult cerebral arteries. These observations suggest that hypomorphic NOTCH3 activity causes alterations in actin organization in CADASIL. Furthermore, arteries from different organs have specific characteristics, which modify the effects of the NOTCH3 mutation and which is one explanation for the exceptional susceptibility of cerebral white matter arteries.
Figures





Similar articles
-
Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway.Clin Sci (Lond). 2021 Mar 26;135(6):753-773. doi: 10.1042/CS20201412. Clin Sci (Lond). 2021. PMID: 33681964
-
ER stress and Rho kinase activation underlie the vasculopathy of CADASIL.JCI Insight. 2019 Dec 5;4(23):e131344. doi: 10.1172/jci.insight.131344. JCI Insight. 2019. PMID: 31647781 Free PMC article.
-
Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.Am J Pathol. 2003 Jan;162(1):329-42. doi: 10.1016/S0002-9440(10)63824-2. Am J Pathol. 2003. PMID: 12507916 Free PMC article.
-
CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia.Brain Pathol. 2002 Jul;12(3):371-84. doi: 10.1111/j.1750-3639.2002.tb00451.x. Brain Pathol. 2002. PMID: 12146805 Free PMC article. Review.
-
[Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)].Rinsho Byori. 2009 Mar;57(3):242-51. Rinsho Byori. 2009. PMID: 19363995 Review. Japanese.
Cited by
-
Progress to Clarify How NOTCH3 Mutations Lead to CADASIL, a Hereditary Cerebral Small Vessel Disease.Biomolecules. 2024 Jan 18;14(1):127. doi: 10.3390/biom14010127. Biomolecules. 2024. PMID: 38254727 Free PMC article. Review.
-
Exonic mutations in cell-cell adhesion may contribute to CADASIL-related CSVD pathology.Hum Genet. 2023 Sep;142(9):1361-1373. doi: 10.1007/s00439-023-02584-8. Epub 2023 Jul 8. Hum Genet. 2023. PMID: 37422595 Free PMC article.
-
Blood vessel organoids generated by base editing and harboring single nucleotide variation in Notch3 effectively recapitulate CADASIL-related pathogenesis.Mol Neurobiol. 2024 Nov;61(11):9171-9183. doi: 10.1007/s12035-024-04141-4. Epub 2024 Apr 9. Mol Neurobiol. 2024. PMID: 38592587 Free PMC article.
-
Novel Cysteine-Sparing Hypomorphic NOTCH3 A1604T Mutation Observed in a Family With Migraine and White Matter Lesions.Neurol Genet. 2021 Apr 22;7(3):e584. doi: 10.1212/NXG.0000000000000584. eCollection 2021 Jun. Neurol Genet. 2021. PMID: 33898742 Free PMC article.
-
Nucleic Acid Therapies for Ischemic Stroke.Neurotherapeutics. 2019 Apr;16(2):299-313. doi: 10.1007/s13311-019-00710-x. Neurotherapeutics. 2019. PMID: 30635869 Free PMC article. Review.
References
-
- Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511–1515. - PubMed
-
- Kalimo H, Miao Q, Tikka S, Mykkanen K, Junna M, Roine S, et al. CADASIL: the most common hereditary subcortical vascular dementia. Future Neurol. 2008;3:683–704.
-
- Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl) 1995;89:500–512. - PubMed
-
- Ruchoux MM, Chabriat H, Bousser MG, Baudrimont M, Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke. 1994;25:2291–2292. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous